ArticlePloS one2024

Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies.

Aram Avila-Herrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.